Gilead signals steps to widen global access to remdesivir for Covid-19 patients
Gilead said it is pursuing several steps to ensure global access to remdesivir for Covid-19 patients, including licensing agreements to supply the drug to countries beyond the U.S.
No hay comentarios:
Publicar un comentario